Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/2001
11/20/2001US6319716 Generating expression vectors; link heterologous sequences, insert into cells, allow homologous recombination, recover expression vectors
11/20/2001US6319710 Isolated nucleic acid molecule operatively linked to a regulatory sequence
11/20/2001US6319709 Tumor cells with increased immunogenicity and uses therefor
11/20/2001US6319704 Nucleotide sequences coding an enzymatic polypeptide; for use in the diagnosis and treatment of nervous system disorders
11/20/2001US6319703 Recombinant virus vectors
11/20/2001US6319700 Human choline acetyltransferase
11/20/2001US6319693 Cloning of chicken anemia virus DNA
11/20/2001US6319689 Nucleotide sequence which code aspartic protease; for treatment of alzheimer's disease, cancer; for hormone processing
11/20/2001US6319688 Polynucleotide encoding human sodium dependent phosphate transporter (IPT-1)
11/20/2001US6319686 Nucleotide sequences coding binding protein; for use as diagnostic, drug design and therapeutic tools
11/20/2001US6319669 Nucleotide sequences coding luminescent polypeptides; for use as genetic tools in monitoring intracelular positions of preferential polypeptides and preferential gene expression
11/20/2001US6319667 Diagnostics and therapy of diseases associated with HHV-8 infections
11/20/2001US6319499 Administering amount of antibody or fragment thereof effective to activate endogenous activity of erythropoietin receptor in mammal, wherein antibody or fragment thereof interacts with peptide consisting of specified amino acid sequence
11/20/2001US6319496 Generation of human cytotoxic T-cells specific for carcinoma self-associated antigens and uses thereof
11/20/2001US6319495 Method for restoring glucose responsiveness to insulin secretion
11/20/2001CA2096418C Expression of pace in host cells and methods of use thereof
11/20/2001CA2077691C Oxidation resistant thrombomodulin analogs
11/20/2001CA2053864C Modified forms of reproductive hormones
11/19/2001CA2324167A1 A membrane-bound netrin
11/18/2001CA2722134A1 Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof
11/18/2001CA2477192A1 Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof
11/15/2001WO2001086307A2 Compositions and methods for the diagnosis, treatment and prevention of steroid hormone responsive cancers
11/15/2001WO2001086293A2 A method for designing and screening random libraries of compounds
11/15/2001WO2001085995A2 Identification of neural defects associated with the nucleosom al assembly protein 1l2 gene
11/15/2001WO2001085993A2 Method for detecting growth hormone variations in humans, the variations and their uses
11/15/2001WO2001085982A2 Mixed cell systems for the detection of viruses
11/15/2001WO2001085981A2 Methods for stimulating nervous system regeneration and repair by regulating arginase i and polyamine synthesis
11/15/2001WO2001085980A2 Enzymatic assays for screening anti-cancer agents
11/15/2001WO2001085974A2 Retroviral vectors comprising an enhanced 3' transcription termination structure
11/15/2001WO2001085973A1 Antisense type gene trap vector
11/15/2001WO2001085963A2 Modification of gene expression in transgenic plants
11/15/2001WO2001085956A2 Lipid metabolism enzymes
11/15/2001WO2001085955A1 Rh116 polypeptides and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
11/15/2001WO2001085954A2 Serine-threonine kinase-3
11/15/2001WO2001085953A1 Sphingosine kinase and uses thereof
11/15/2001WO2001085952A2 Modified inosine 5'-monophosphate dehydrogenase polypeptides and uses thereof
11/15/2001WO2001085950A2 Genes of the 1-desoxy-d-xylulose biosynthesis path
11/15/2001WO2001085946A2 Nucleic acid molecules encoding plant cell cycle proteins and uses therefor
11/15/2001WO2001085944A2 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor
11/15/2001WO2001085942A2 Cytoskeleton-associated proteins
11/15/2001WO2001085938A1 Modified es cells and es cell-specific gene
11/15/2001WO2001085937A2 Regulator of g protein signalling (rgs8)
11/15/2001WO2001085936A1 F-box containing protein
11/15/2001WO2001085935A2 Endothelial differentiation gene 6-like g protein coupled receptor
11/15/2001WO2001085934A1 New ras guanine-nucleotide-exchange factor 1 (nrg1)
11/15/2001WO2001085930A2 Methods and compounds for modulating melanocortin receptor ligand binding and activity
11/15/2001WO2001085926A2 Nucleotide sequences involved in increasing or decreasing mammalian ovulation rate
11/15/2001WO2001085921A2 Human serine-threonine kinase-4
11/15/2001WO2001085920A2 Compositions and methods for producing antigen-presenting cells
11/15/2001WO2001085919A1 Hiv-producing cell line and use thereof
11/15/2001WO2001085917A2 A device
11/15/2001WO2001085913A2 High purity x-chromosome bearing and y-chromosome bearing populations of spermatozoa
11/15/2001WO2001085905A2 Isolated gum operon from xyllela fastidiosa, isolated nucleic acid molecules therefrom, and uses thereof
11/15/2001WO2001085798A2 Human monoclonal antibodies to dendritic cells
11/15/2001WO2001085797A1 Human igm antibodies with the capability of inducing remyelination, and diagnostic and therapeutic uses thereof particularly in the central nervous system
11/15/2001WO2001085792A2 Mu-1, member of the cytokine receptor family
11/15/2001WO2001085790A2 Mammalian cytokine receptor subunit proteins, related reagents and methods
11/15/2001WO2001085787A2 Stable rxr expressing cell line
11/15/2001WO2001085785A2 Ph domain-interacting protein
11/15/2001WO2001085779A2 Protein complexes and assays for screening anti-cancer agents
11/15/2001WO2001085772A2 Virulence genes, proteins, and their use
11/15/2001WO2001085766A2 Novel eosinophil cationic proteins used in the treatment of asthmatic and allergic disorders
11/15/2001WO2001085762A2 Cancer diagnosis and assays for screening anti-cancer agents
11/15/2001WO2001085210A2 Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth
11/15/2001WO2001085207A2 Modulation of antigen processing using phagocytic cells
11/15/2001WO2001085196A2 Cxcr4 antagonist treatment of hematopoietic cells
11/15/2001WO2001085193A2 Method for promoting neovascularization using a tweak agonist and an angiogenic factor
11/15/2001WO2001084933A1 A homeodomain protein code specifying progenitor cell identity and neuronal fate in the ventral neural tube
11/15/2001WO2001060981A8 Tooth progenitor cell and method for its production
11/15/2001WO2001036001A3 Interferon gamma conjugates
11/15/2001WO2001032882A3 Nucleic acids and proteins from group b streptococcus
11/15/2001WO2001032878A3 A novel polypeptide hormone phosphatonin
11/15/2001WO2001019974A3 Recombinant microorganisms
11/15/2001WO2001016292A8 37 staphylococcus aureus genes and polypeptides
11/15/2001WO2001010899A3 Treatment of liver disease and injury with cxc chemokines
11/15/2001WO2001002594A3 DNA CONSTRUCTS BASED ON THE eIF4A GENE PROMOTER
11/15/2001WO2001002550A3 Cell death related drug targets in yeast and fungi
11/15/2001WO2000078344A8 Prion protein peptides and uses thereof
11/15/2001WO2000063379A3 The p2x3 receptor, methods of altering p2x3 receptor activity and uses thereof
11/15/2001WO2000053232A9 Matriptase, a serine protease and its applications
11/15/2001WO2000047627A9 Agents that bind to and inhibit human cytochrome p450 2c8, 2c9, 2c18 and 2c19
11/15/2001WO2000026370A9 Adenine nucleotide translocator (ant) fusion proteins and uses thereof
11/15/2001WO2000015819A9 Packaging cell lines for hiv-derived retroviral vector particles
11/15/2001US20010042255 Nucleic acids
11/15/2001US20010041679 Multiple site delivery of adenoviral vector for the induction of angiogenesis
11/15/2001US20010041668 Selecting compound that is functionally equivalent to a gene product expressed in an embryo's extraembryonic tissue, causing the compound to access the cells to stimulate cells to undergo hematopoiesis and vascular growth
11/15/2001US20010041363 Hollow fiber bioreactor; filtration
11/15/2001US20010041361 Method for enhanced protein stabilization and for production of cell lines useful for production of such stabilized proteins
11/15/2001US20010041354 Genetic engineering
11/15/2001US20010041346 Complex of cyclic guanosine monophosphate protein kinase and myosin phosphatase
11/15/2001US20010041342 Using apoptosis inhibiting protein
11/15/2001US20010041331 Methods of utilizing the TT virus
11/15/2001US20010041178 Preventing airway mucus production by administration of EGF-R antagonists
11/15/2001US20010041174 Use of implanted encapsulated cells expressing glutamate transporter proteins for the treatment of neurodegenerative diseases
11/15/2001DE10022362A1 Verfahren zum Auffinden von Modulatoren von Enzymen des Carotenoid-Biosyntheseweges A method for finding modulators of enzymes of the carotenoid biosynthesis pathway
11/15/2001DE10021688A1 New DNA sequences involved in isoprenoid biosynthesis, useful in screening for compounds with e.g. antimicrobial and herbicidal activity
11/15/2001DE10021627A1 Verfahren zur Herstellung eines vaskularisierten bioartifiziellen Gewebes und zugehöriger Versuchsreaktor A method for producing a bioartificial vascularized tissue and associated experimental reactor
11/15/2001CA2804977A1 Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth
11/15/2001CA2803844A1 Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth
11/15/2001CA2803774A1 A particle differentiation apparatus for spermatozoa